| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 42.92M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MEOBF returned +7.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -13.2% |
| 1 year | +7.1% |
| 5 years | +27.9% |
| 10 years | +38.7% |
| All-time high | $10.64 (Oct 2011) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MEOBF would be worth today ›No. Mesoblast Limited has not paid a dividend in the past 12 months.
Mesoblast Limited is part of the Healthcare sector.
Mesoblast Limited has a market cap of 2.14B USD, based on the latest quote.
Mesoblast Limited is scheduled to report earnings on Aug 26, 2026.
